Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

(NasdaqGM:RANI), Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit royalties on product sales for the first license agreement Chugai has the option to extend its rights to partner with Rani on […]

Exgen Resources and MTB Metals Enter Into Arrangement Agreement to Merge, Creating a Well Funded Copper, Gold and Lithium Exploration and Development Company

(TSX-V:EXG),(OTC US:BXXRF),(Other OTC:BXXRF),(TSX-V:MTB),(Other OTC:MBYMF),(Frankfurt:M9U), VANCOUVER, British Columbia, Oct. 17, 2025 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen“, the “Company“) and MTB Metals Corp. (TSXV: MTB, OTCQB: MBYMF, Frankfurt: M9U) (“MTB“): ExGen and MTB are pleased to announce that they have entered into an Arrangement Agreement dated October 16, 2025 (the “Arrangement“).

PharmaCorp Rx Inc. Files Final Short Form Base Shelf Prospectus

(TSX-V:PCRX), SASKATOON, Saskatchewan, Oct. 17, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation“) (TSXV:PCRX) is pleased to announce that it has filed its Final Short Form Base Shelf Prospectus dated October 14, 2025 (the “Prospectus“) with the securities commissions in each of the provinces of Canada, other than Quebec. The Prospectus allows

StorageVault Finalizes and Receives Additional Expropriation Compensation, and Grows Third Party Management Platform

(TSX:SVI), TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault“) (SVI-TSX) is pleased to announce that it has finalized and received proceeds related to the expropriation of one of its properties and that it has added two-third party stores to its third party management platform. StorageVault will record an additional $15 million gain

Achieve Life Sciences Receives FDA Commissioner’s National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

(NASDAQ:ACHV), Potential First-in-Class Treatment for Nicotine E-cigarette or Vaping Cessation Receives Unprecedented Expedited Review Pathway One of Only Nine Therapies Chosen for the FDA's Inaugural National Priority Voucher Program SEATTLE and VANCOUVER, British Columbia, Oct. 17, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global

Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors

(NASDAQ:PRLD), WILMINGTON, Del., Oct. 17, 2025 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the appointment of Katina Dorton to its Board of Directors, effective today. Ms. Dorton has more than 30 years of industry expertise and leadership in healthcare and life sciences including service on several boards

Paratek Pharmaceuticals to Present New Data on NUZYRA(R) (omadacycline) at IDWeek 2025 and CHEST 2025

Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in nontuberculous mycobacterial pulmonary disease (NTM-PD) caused by Mycobacterium abscessus complex (MABc), as well as additional clinical and non-clinical data from Company- and investigator-sponsored studies KING OF PRUSSIA, Pa. and BOSTON, Oct. 17, 2025

Investors Urged to Contact Levi & Korsinsky for Information Before November 17, 2025 – Cytokinetics, Incorporated (CYTK)

NEW YORK CITY, NY / ACCESS Newswire / October 17, 2025 / NEW YORK, NY / ACCESS Newswire / October 17, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=172655&wire=1&utm_campaign=5

Paratek Pharmaceuticals to Present New Data on NUZYRA(R) (omadacycline) at IDWeek 2025 and CHEST 2025

Paratek Pharmaceuticals to Present New Data on NUZYRA(R) (omadacycline) at IDWeek 2025 and CHEST 2025 GlobeNewswire October 17, 2025 Highlights include clinical data from Phase 3 studies in Community Acquired Pneumonia (CABP) and microbiologic data from a Phase 2 study in nontuberculous mycobacterial pulmonary disease (NTM-PD) caused by Mycobacterium abscessus complex (MABc), as well as

ZENITH BANK PLC WINS BIG AT GLOBAL BRANDS AWARDS 2025

Global Brands Magazine Honors Zenith Bank PLC with Two Prestigious Awards: Best Website Design & User Experience and Best Bank in Digital Marketing, Nigeria, 2025. These accolades celebrate Zenith Bank's exceptional leadership in delivering innovative digital solutions and impactful marketing strategies in Nigeria's financial services sector. https://mma.prnewswire.com/media/2648066/5568931/GBM_Awards_2025_Logo.jpg The Global Brand Awards celebrate outstanding achievements across

Scroll to Top